What does it really take to bring a NeuroTech medical device from idea to market? Join NAMSA and a panel of renowned Key Opinion Leaders – Dr. Brian Litt (neurologist and bioengineering pioneer) and Dr. James Kryzanski (neurosurgeon and medical device entrepreneur) – as they explore the hottest trends in NeuroTech medical device development, regulatory and clinical strategies in getting to market and being successful, and what payers and clinicians expect from clinical evidence.

Key Learning Objectives:

• Understand the hottest trends in NeuroTech in 2026
• Understand what companies need to succeed: Addressing the unmet need and overcoming the challenges of regulatory authorization, reimbursement coverage, and clinical adoption
• Understand how to design preclinical and clinical studies that generate bench, animal, and human evidence that not only satisfy regulatory requirements but also prove value for payers and clinicians
• Understand how NeuroTech is uniquely positioned to advance and take advantage of decentralized clinical trials

For more information and to register click here.